Mayo Clinic develops precision medicine genomic diagnostic test for lymphoma
The new Lymph2Cx test can accurately diagnose non-Hodgkins lymphoma and help determine treatment regimens in ways that Mayo Clinic doctors said have the potential to transform patient care.
Powered by WPeMatico
